Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

TRI-LUMA

FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN

Standard Dose
0.01%;4%;0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TRI-LUMA is listed in Drugs@FDA under application 021112 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN Form and strength CREAM;TOPICAL - 0.01%;4%;0.05% Sponsor GALDERMA LABS LP Submission history Latest submission status date: 2015-01-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRI-LUMA is listed in Drugs@FDA under application 021112 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN Form and strength CREAM;TOPICAL - 0.01%;4%;0.05% Sponsor GALDERMA LABS LP Submission history Latest submission status date: 2015-01-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TRI-LUMA (FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN) | Drug Monograph | MedicHelpline